FEATURED ARTICLES
Regeneron’s second annual Digital Biomarkers Summit is a good example of how competing pharma companies can work together in a noncompetitive environment for the industrywide goal of advancing the use of digital biomarkers in clinical trials.
-
Multidisciplinary Collaborations Fuel New Glioma Treatment Breakthroughs
Servier's Susan Pandya, MD, vice president of clinical development, shares what can be achieved when scientists, patients, investigators, and advocacy groups collaborate to create an innovative trial design for a potential breakthrough therapy.
-
Unleashing The Power Of Investigator-Sponsored Research (ISR) And Investigator-Initiated Trials (IIT)
Investigator-sponsored research (ISR) and investigator-initiated trials (IIT) are essential to expanding the drugs currently available or under investigation, either alone or in combination, to address unmet medical needs.
-
Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.